AMR Conference Program Pitch finalists

 Start-up pitch

The start-up pitch session is supported by INCATE. Ten finalists will be selected that have the opportunity to make a 5-minute-pitch of their venture in the start-up pitch session on March 3, 2026. The best pitch will win a 10,000 € prize from award sponsor Vossius, one of the leading IP law firms in Europe.

Proudly presenting the finalists

Triari Pharmaceuticals

Presented by: John A. Zurawski

Website: http://www.triaripharma.co

The innovation in one sentence: Optimized monoclonal antibodies targeting novel epitopes on the surface of P. aeruginosa.
Watch Pitching video

Luminicell

Presented by: Jax Lee

Website: www.luminicell.com

The innovation in one sentence: A Novel Class of Antimicrobial Drugs for Fungal Infections.
Watch Pitching video

Resistia

Presented by: Ignacio Massone
 
 
The innovation in one sentence: Resistia is developing bio-therapies based on microbiota compounds to target resistant biofilm-related infections.
Watch Pitching video

Hermione Therapeutics

Presented by: Anne Michel
 
 
The innovation in one sentence: Take control over exacerbations in chronic respiratory diseases from 1st intent and prevent resistance to occur.
Watch Pitching video

Arrowsmith

Presented by: Ayaka Washizaki

Website: https://arrowsmith.co.jp/

The innovation in one sentence: Arrowsmith is a Japan-based startup developing engineered phage therapies for AMR, leveraging our synthetic engineering platform with a lead program ARW001 for Pseudomonas aeruginosa targeting IND submission in 2026.
Watch Pitching video

MetalloBio

Presented by: Michael Murray

Website: https://www.metallobio.com/

The innovation in one sentence: MetalloBio is exploiting its proprietary inorganic chemistry platform to develop totally new classes of broad spectrum antibiotic candidates for drug development to tackle complicated infections and to generate antibacterial coatings for medical devices and civilian uses.
Watch Pitching video

Baxiva

Presented by: Giorgia Greter

Website: https://www.baxiva.com/

The innovation in one sentence: Next-generation glycoconjugate vaccines to fight E. coli.
Watch Pitching video

Arvalus

Presented by: Christian Brandstetter

Website: https://arvalus-therapeutics.com/

The innovation in one sentence: Arvalus is pioneering a next-generation live biotherapeutic product (LBP) engineered to precisely target and eradicate multi-drug-resistant and pathogenic bacteria from the gut.
Watch Pitching video

80SBIO

Presented by: Arka Banerjee

Website: https://www.linkedin.com/company/80sbio-gmbh/

The innovation in one sentence: QuantR detects AMR rapidly, even before the first cycle of cell division by detecting the replication of RNA that precedes cell division.
Watch Pitching video

AstralytiX (KU Leuven)

Presented by: Katrien Trappeniers

Website: under construction

The innovation in one sentence: FibriLysins – Breaking barriers, defeating resistance. A novel class of endolysins to cure difficult-to-treat staphylococcal infections.
Watch Pitching video